Advanced Medical Isotope (RDGL)
(Delayed Data from OTC)
$0.19 USD
-0.03 (-14.34%)
Updated Jun 26, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RDGL 0.19 -0.03(-14.34%)
Will RDGL be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for RDGL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RDGL
Alset And 2 Other Stocks Under $2 Insiders Are Buying
Catalyst Watch: Disney earnings, Apple iPad event and Fed speakers back on the circuit